Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase

British Journal of Pharmacology

Volumn 155, Issue 3, 2008, Pages 335-342

  Oppermann, M ^a   Dao, V T V ^a   Suvorava, T ^a   Bas, M ^b   Kojda, G ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chronic treatment; Endothelium; Nitric oxide; Nitric oxide synthase; Organic nitrates; Soluble guanylyl cyclase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; ISOSORBIDE MONONITRATE; N ACETYL S NITROSOPENICILLAMINE; PENTAERYTHRITYL TETRANITRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG MEGADOSE; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; VASCULAR SMOOTH MUSCLE;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANYLATE CYCLASE; ISOSORBIDE DINITRATE; LUNG; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE DONORS; PENTAERYTHRITOL TETRANITRATE; PROTEIN SUBUNITS; RABBITS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VASODILATOR AGENTS;

EID: 52949123235     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.269     Document Type: Article

References (45)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC). Br J Pharmacol, 3rd edn. 153 (Suppl 2): S1-S209.
2. Bauersachs J, Bouloumié A, Mülsch A, Wiener G, Fleming I, Busse R (1998). Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO sythase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc Res 37: 772-779.
3. Brandes RP, Kim DY, Schmitz-Winnenthal FH, Amidi M, Gödecke A, Mülsch A et al. (2000). Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice - role of soluble guanylyl cyclase. Hypertension 35: 231-236.
4. Browner NC, Dey NB, Bloch KD, Lincoln TM (2004). Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. J Biol Chem 279: 46631-46636.
5. Buechler WA, Nakane M, Murad F (1991). Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun 174: 351-357.
6. Chen LH, Daum G, Fischer JW, Hawkins S, Bochaton-Piallat ML, Gabbiani G et al. (2000). Loss of expression of the β subunit of soluble guanylyl cyclase prevents nitric oxide-mediated inhibition of DNA synthesis in smooth muscle cells of old rats. Circ Res 86: 520-525.
7. Chen Z, Zhang J, Stamler JS (2002). Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 99: 8306-8311.
8. Filippov G, Bloch DB, Bloch KD (1997). Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942-948.
9. Francois M, Kojda G (2004). Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway. Neurochem Int 45: 955-961.
10. Friebe A, Koesling D (2003). Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93: 96-105.
11. Gewaltig MT, Kojda G (2002). Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 55: 250-260.
12. Hussain MB, Hobbs AJ, MacAllister RJ (1999). Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta. Br J Pharmacol 128: 1082-1088.
13. Ignarro LJ, Cirino G, Casini A, Napoli C (1999). Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34: 879-886.
14. Kleschyov AL, Oelze M, Daiber A, Huang Y, Mollnau H, Schulz E et al. (2003). Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res 93: e104-e112.
15. Kloss S, Bouloumie A, Mulsch A (2000). Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 35: 43-47.
16. Kloss S, Furneaux H, Mulsch A (2003). Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta. J Biol Chem 278: 2377-2383.
17. Kojda G, Kottenberg K, Hacker A, Noack E (1998a). Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long-term hypertension in rats. Pharm Acta Helv 73: 27-35.
18. Kojda G, Kottenberg K, Nix P, Schlüter KD, Piper HM, Noack E (1996). Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78: 91-101.
19. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, Burchfield J et al. (1999). Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc Res 42: 206-213.
20. Kojda G, Patzner M, Hacker A, Noack E (1998b). Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate. A novel mechanism to explain preferential venodilation of organic nitrates. Mol Pharmacol 53: 547-554.
21. Kojda G, Stein D, Kottenberg E, Schnaith EM, Noack E (1995). In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits. J Cardiovasc Pharmacol 25: 763-773.
22. Krumenacker JS, Hyder SM, Murad F (2001). Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus. Proc Natl Acad Sci USA 98: 717-722.
23. Laber U, Kober T, Schmitz V, Schrammel A, Meyer W, Mayer B et al. (2002). Effect of hypercholesterolemia on expression and function of vascular soluble guanylyl cyclase. Circulation 105: 855-860.
24. McGuire JJ, Anderson DJ, McDonald BJ, Narayanasami R, Bennett BM (1998). Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate. Biochem Pharmacol 56: 881-893.
25. Melichar VO, Behr-Roussel D, Zabel U, Uttenthal LO, Rodrigo J, Rupin A et al. (2004). Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci USA 101: 16671-16676.
26. Minamiyama Y, Takemura S, Akiyama T, Imaoka S, Inoue M, Funae Y et al. (1999). Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. FEBS Lett 452: 165-169.
27. Momi S, Impagnatiello F, Guzzetta M, Caracchini R, Guglielmini G, Olivieri R et al. (2007). NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. Eur J Pharmacol 570: 115-124.
28. Moncada S, Higgs A (1993). Mechanisms of disease: the L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012.
29. Mullenheim J, Muller S, Laber U, Thamer V, Meyer W, Bassenge E et al. (2001). The effect of high-dose pentaerythritol tetranitrate on the development of nitrate tolerance in rabbits. Naunyn Schmiedebergs Arch Pharmacol 364: 269-275.
30. Muller S, Konig I, Meyer W, Kojda G (2004). Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J Am Coll Cardiol 44: 624-631.
31. Muller S, Laber U, Mullenheim J, MeyerW, Kojda G (2003). Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance. J Am Coll Cardiol 41: 1994-2000.
32. Mullershausen F, Russwurm M, Koesling D, Friebe A (2003). The enhanced NO-induced cGMP response induced by long-term L-NAME treatment is not due to enhanced expression of NO-sensitive guanylyl cyclase. Vascul Pharmacol 40: 161-165.
33. Mülsch A, Mordvintcev P, Bassenge E, Jung F, Clement B, Busse R (1995). In vivo spin trapping of glyceryl trinitrate-derived nitric oxide in rabbit blood vessels and organs. Circulation 92: 1876-1882.
34. Mulsch A, Oelze M, Kloss S, Mollnau H, Topfer A, Smolenski A et al. (2001). Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation 103: 2188-2194.
35. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, Catravas JD (1996). Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β. Br J Pharmacol 118: 1359-1366.
36. Ruetten H, Zabel U, LinzW, Schmidt HHHW (1999). Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 85: 534-541.
37. Russwurm M, Koesling D (2004). NO activation of guanylyl cyclase. EMBO J 23: 4443-4450.
38. Schmidt K, Andrew P, Schrammel A, Groschner K, Schmitz V, Kojda G et al. (2001). Comparison of neuronal and endothelial isoforms of nitric oxide synthase in stably transfected HEK 293 cells. Am J Physiol Heart Circ Physiol 281: H2053-H2061.
39. Schultz G, Böhme E (1984). Guanylate Cyclase. In: Bergmeyer HU (ed). Methods of Enzymatic Analysis. Verlag Chemie: Weinheim, FRG, pp 379-389.
40. Scott WS, Nakayama DK (1998). Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle. J Surg Res 80: 309-314.
41. Shimouchi A, Janssens SP, Bloch DB, Zapol WM, Bloch KD (1993). cAMP regulates soluble guanylate cyclase β1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 265: L456-L461.
42. Takata M, Filippov G, Liu H, Ichinose F, Janssens S, Bloch DB et al. (2001). Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol 280: L272-L278.
43. Weber M, Lauer N, Mulsch A, Kojda G (2001). The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Free Radic Biol Med 31: 1360-1367.
44. Wenzel P, Hink U, Oelze M, Seeling A, Isse T, Bruns K et al. (2007). Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice. Br J Pharmacol 150: 526-533.
45. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y, Inoue N et al. (2000). Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36: 97-102.